Skip to main content

Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Spectral Medical Inc down on Monday (EDT)

Automated Summaries - The Globe and Mail - Mon Apr 1, 4:01PM CDT

Today in trading, shares of Spectral Medical Inc opened at $0.47 and closed at $0.46. prices ranged from a low of $0.46 to a high of $0.47.

Share prices dipped -2.13 percent from the previous day's close of $0.47.

During the day across North America, the TSX Composite closed 0.27% at 22167.03, the S&P 500 closed 0.11% at 5254.35, the Dow Jones Industrial Average closed 0.12% at 39807.37 and the Nasdaq Composite closed -0.12% at 16379.46.

Spectral Medical Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EDT.

Trading volume was 13,000 on 4 total trades. On average, Spectral Medical Inc has traded 45,209 shares over 5 days and 118,693 year-to-date.

The TSX market on the whole today saw 1,761 price advancers against 3,499 declines and 110 unchanged.

During the prior 52 weeks, EDT.TO has traded as high as $0.67 (February 07,2024) and low as $0.23 (June 14,2023). Moreover, in the last 12 months, Spectral Medical Inc's shares have advanced 41.54%, while they have advanced 8.24% year-to-date.

It announced a 0.12 dividend on November 29/11, with an December 19/11 ex-date and January 20/12 pay day.

Following today's trading, Spectral Medical Inc has a market capitalization of $130.93 million on a float of 278,576 shares outstanding. Its annual EPS is $-0.05.

Spectral Medical Inc is a None company headquartered in Toronto, CAN.

Currently, Spectral Medical Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe